Novavax to Participate in Upcoming Investor Conferences

5/29/25 8:00:00 AM ET

Biotechnology: Biological Products (No Diagnostic Substances)

Health Care

Get the next $NVAX alert in real time by email

GAITHERSBURG, Md., May 29, 2025 /PRNewswire/ -- Novavax, Inc. (NASDAQ:NVAX) today announced that it will participate in the following upcoming investor conferences:

Jefferies Global Healthcare Conference:
Fireside Chat
Date:	Wednesday, June 4, 2025
Time:	2:00 – 2:30 p.m. Eastern Time (ET)
Location:	New York, NY


Goldman Sachs 46^th Annual Global Healthcare Conference:
Presentation
Date:	Wednesday, June 11, 2025
Time:	2:00 – 2:35 p.m. ET
Location:	Miami Beach, FL

A webcast of the fireside chat and presentation will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcasts will be available for 30 days.

About Novavax

Novavax, Inc. (NASDAQ:NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M^® adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via research and development innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information.

Contacts:

Investors

Luis Sanay, CFA

240-268-2022

[email protected]

Media

Giovanna Chandler

202-709-5563

[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-upcoming-investor-conferences-302467664.html

SOURCE Novavax, Inc.

Get the next $NVAX alert in real time by email

Recent Analyst Ratings for

$NVAX

Date	Price Target	Rating	Analyst
6/17/2025	$6.00	Sell	Citigroup
2/28/2025	$19.00	Buy	BTIG Research
7/30/2024	$8.00	Neutral → Underweight	JP Morgan
5/10/2024	$4.00 → $12.00	Underperform → Neutral	BofA Securities
5/10/2024		Underweight → Neutral	JP Morgan
8/9/2023	$15.00	Neutral → Buy	B. Riley Securities
4/20/2023	$55.00 → $10.00	Outperform → Market Perform	TD Cowen
3/1/2023	$29.00 → $10.00	Buy → Neutral	B. Riley Securities

More analyst ratings

Novavax to Participate in Upcoming Investor Conferences

Chat with this insight

Recent Analyst Ratings for
$NVAX

$NVAX
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Mcglynn Margaret G converted options into 10,420 shares, increasing direct ownership by 69% to 25,588 units (SEC Form 4)

Director Alton Gregg H converted options into 10,420 shares, increasing direct ownership by 57% to 28,805 units (SEC Form 4)

Director King Rachel K. converted options into 10,420 shares, increasing direct ownership by 71% to 25,190 units (SEC Form 4)

Novavax to Participate in Upcoming Investor Conferences

Chat with this insight

Recent Analyst Ratings for $NVAX

$NVAX Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Director Mcglynn Margaret G converted options into 10,420 shares, increasing direct ownership by 69% to 25,588 units (SEC Form 4)

Director Alton Gregg H converted options into 10,420 shares, increasing direct ownership by 57% to 28,805 units (SEC Form 4)

Director King Rachel K. converted options into 10,420 shares, increasing direct ownership by 71% to 25,190 units (SEC Form 4)

Recent Analyst Ratings for
$NVAX

$NVAX
Insider Trading